Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

Masashi AndoKazunori HondaWaki HosodaYuki MatsubaraRyosuke KumanishiTaiko NakazawaTakatsugu OgataAkinobu NakataHiroyuki KodamaToshiki MasuishiYukiya NaritaHiroya TaniguchiShigenori KadowakiKei Muro

Published in: International journal of clinical oncology (2023)

The outcome of patients with unfavorable-risk CUP remains to be poor. Site-specific therapy based on IHC is not recommended for all patients with unfavorable-risk CUP.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
lymph node metastasis
squamous cell carcinoma
patient reported outcomes
cell therapy